The Share and Stock Market is one of the most important ways for companies to raise their money through shares, and the objective of this blog is to provide you daily intraday news regarding stock market. You have arrived at the right place and you'll find a lot of information here on intraday news updates— basic concepts, strategies for buying and selling, time of entry and exit and a lot more.
Here are five stocks that brokerage firms are watching out:
Motherson Sumi With maintaining buy rating on Motherson Sumi with a target price of Rs 356, UBS says it is a multi-year story and expects 24 percent EPS CAGR over FY16-19 period. The brokerage house sees margin improvement at Samvardhana Motherson Peguform and expects international business growth to remain robust. The company has a solid track record of generating value by turning around distressed assets. UBS says Samvardhana Motherson Reflectec continues to gain share in the US market and India business will grow faster than domestic car production.
Jammu & Kashmir Bank CLSA has upgraded the stock to buy and raised target price to Rs 77 from Rs 65 earlier on a reasonable valuations but slashed earnings growth estimates. It says recovery of the J&K state will be key for better operational efficiency and remains conversative on management's indication of growth from next year. Bank's CASA franchise remains strong and contributed 45 percent of deposits (which grew by 17 percent YoY), it says, adding demonetisation could further boost profit.
Pharma stocks Bank of America Merrill Lynch says US generic pricing environment further muddled by litigations. According to the brokerage house, greater scrutiny could lower the occurrence of opportunistic price hikes. It says 1 percent increase in price erosion in US leads to 1.5-4 percent impact on EPS. It prefers Lupin & Biocon in Indian pharma space. Lupin is only large cap company with no pending regulatory issues. BoAML prefers Biocon as it's a strong proxy to the biosimilar opportunity and Biocon is likely to be largely unaffected by generic pricing concerns.
Oil marketing companies Citi says fuel price hike should lay to rest investor concerns. It has maintained buy call on all 3 oil marketing companies with BPCL as preferred pick. It feels downside should be limited given non-discretionary nature of fuel purchases. According to the brokerage house, worst-case EPS impact for BPCL/HPCL/IOC is likely to be 8/13/7 percent.